Product Description
Since last manyyears Saintroy Lifescience is leading manufacture, export and supplierofMitoxantrone Injection from Surat, Gujarat, India. Mitoxantrone Injection used to treat certain types of cancer, mostly acute myeloid leukemia. It improves the survival rate of children suffering from acute lymphoblastic leukemia relapse.
Tags: Mitoxantrone Injection manufacturer, Mitoxantrone Injection exporter, Mitoxantrone Injection supplier,and Mitoxantrone Injection, whogmp approved Mitoxantrone Injection manufacturer andsupplier, Mitoxantrone Injection distributor, Mitoxantrone Injection shipper,Mitoxantrone Injection 10 ml Mitoxantrone Injection 10 ml supplier,Mitoxantrone Injection 10 ml.
ISO/GMP/cGMP/WHOGMP/NAFDAC approved, PPB Kenya approved/USFDA approved/EUGMP approved/MOH Iran approved manufacturingfacility in Gujarat, India.
Registration: Saintroy Lifescience is interested in registrationof own brand or customer brands in ministry of health of clientscountry and we also provide the products samples, COA, COPP, ACTD or CTD dossier, DMF, Manufacturing license, Free sales certificate and other required documents.
Export Country :Saintroy LifescienceMitoxantrone Injectionexport to USA, Canada, Germany, Europe, France, Ghana, Nigeria,Kenya, Senegal, Sudan,UAE, Kuwait, Dubai, Cameroon, Lebanon, Peru, Chile,Somalia, Philippines, Myanmar, Maldives, Thailand, Singapore, Malaysia, HongKong, China, Zimbabwe, Togo, Burkina Faso, Niger,Guinea Bissau, Congo,Democratic of republic, Ivory Costa, Oman, Guatemala, Nicaragua, Salvador,Qatar, Costa Rica, Panama, Cuba, Colombia, Bolivia, Argentine, Algeria, Guyana,Morocco, Jordan, Bahrain, Iran, Egypt, Kyrgyzstan, Uzbekistan, Kazakhstan.
Targeted Uses and Therapeutic BenefitsMitoxantrone Injection is prescribed for the management of several malignancies, including breast cancer, leukemia, and lymphoma. It is also indicated for certain cases of multiple sclerosis. Its targeted mechanism provides effective disease control, making it a valuable therapy in clinical oncology and neurology.
Safe Handling and Administration GuidelinesDue to its cytotoxic nature, Mitoxantrone Injection must be handled only by trained healthcare professionals wearing appropriate protective equipment. The solution is ready to use and meant for intravenous administration, ensuring ease of preparation and reducing potential handling errors. Compatibility restrictions require it to be administered without mixing with other drugs in the same syringe.
Storage and Disposal RecommendationsPreserve Mitoxantrone Injection in a cool, dry environment and use the solution within 2 days after opening to ensure efficacy and safety. Disposal must adhere to local regulations for cytotoxic agents to prevent environmental contamination and maintain workplace safety.
FAQ's of Mitoxantrone Injection:
Q: How should Mitoxantrone Injection be administered for optimal safety and effectiveness?
A: Mitoxantrone Injection should be administered intravenously by a healthcare professional using protective equipment due to its cytotoxicity. It is supplied ready-to-use and should not be mixed with other medications in the same syringe. The dosage and frequency are determined by the prescribing physician based on the specific indication.
Q: What are the therapeutic benefits of using Mitoxantrone Injection?
A: Mitoxantrone Injection is effective in treating cancer (including breast cancer, leukemia, and lymphoma) and certain types of multiple sclerosis. By targeting rapidly dividing cells, it helps slow disease progression and improve patient outcomes in these conditions.
Q: When should Mitoxantrone Injection be discarded after opening?
A: Once the vial has been opened, Mitoxantrone Injection must be used within 2 days. Any unused solution should be disposed of properly according to local regulations governing cytotoxic agents.
Q: Where should Mitoxantrone Injection be stored to maintain its stability?
A: Store this injection in a cool and dry place, away from direct sunlight and moisture. Proper storage ensures the medication remains effective until it is required for administration.
Q: What precautions are necessary during the handling of Mitoxantrone Injection?
A: Due to its cytotoxic nature, healthcare personnel must wear protective gloves, gowns, and goggles while handling Mitoxantrone Injection. All preparation and administration steps should be performed in compliance with standard safety protocols for cytotoxic agents.
Q: How should unused or expired Mitoxantrone Injection vials be properly disposed of?
A: Dispose of all vials and materials used in the administration of Mitoxantrone Injection in accordance with local regulations for cytotoxic waste. This helps ensure environmental safety and prevents accidental exposure.